Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04190901 · ClinicalTrials.gov registry record · NA
Effect of Physician Race and Gender on Simulated Patients' Ratings
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 3,592
- Enrollment target
NCT04190901: Completed NA study, sponsored by Yale University.
NCT04190901 is a NA study that has completed, run by Yale University. The registered enrollment target is 3,592 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (156% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04190901, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,592 participants
- Enrollment target
Study Summary
The purpose of the study was to determine whether the race and gender of a simulated doctor affected analog patients' reported confidence and satisfaction in the simulated doctor's diagnosis and treatment plan. The study used two randomized patient analog experiments. This study is complete and pre-analysis plans (PAPs) for each experiment were published prior to data collection. The PAPs are available at: http://aspredicted.org/blind.php?x=43xj25 (Study 1) and https://aspredicted.org/blind.php?x=369st7 (Study 2).
Primary Outcome
1. "How confident are you that this doctor made the correct diagnosis?" Study 1: \[not at all confident (0) to completely confident (100)\] Study 2: \[not at all confident (1) to completely confident (5)\]\* 2. "How confident are you that this doctor made the correct treatment plan?" Study 1: \[not at all confident (0) to completely confident (100)\] Study 2: \[not at all confident (1) to completely confident (5)\]\* * The Patient Confidence outcome for each study participant was the unweigh
Interventions
- BEHAVIORAL Simulated Black Male Physician
- BEHAVIORAL Simulated Black Female Physician
- BEHAVIORAL Simulated White Male Physician
- BEHAVIORAL Simulated White Female Physician
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,592 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
What the finished NCT04190901 record still lists
NCT04190901 is an interventional study that assigns participants to a tested intervention. Its 3,592 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (156% higher).
The record links to 0 conditions, and to 4 interventions - of which Simulated Black Male Physician is the first listed.
NCT04190901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04190901 about?
NCT04190901 is a clinical study titled "Effect of Physician Race and Gender on Simulated Patients' Ratings". The purpose of the study was to determine whether the race and gender of a simulated doctor affected analog patients' reported confidence and satisfaction in the simulated doctor's diagnosis and treatment plan. The study used two randomized patient analog experiments. This study is complete and pre...
What is the current status of trial NCT04190901?
This trial is currently completed. It is a NA study. The enrollment target is 3,592 participants. The study started on 2018-03-09. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT04190901?
The interventions under investigation include: Simulated Black Male Physician (BEHAVIORAL), Simulated Black Female Physician (BEHAVIORAL), Simulated White Male Physician (BEHAVIORAL), Simulated White Female Physician (BEHAVIORAL).
Who is sponsoring clinical trial NCT04190901?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04190901's enrollment target sits among peer trials
3,592 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
- NCT07091032 · 3,600 participants · NA
Building Connections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI